Tipifarnib Shows Responses in HRAS-Mutant Head and Neck Cancers

A new inhibitor may help patients with a certain subset of head and neck squamous cell carcinoma.

Source: CancerNetwork - October 30, 2019 Category: Cancer & Oncology Authors: Seth Augenstein Source Type: news